ERBB2 and inflammatory breast carcinoma: These tumors lack receptors for estrogen, progesterone, or human epidermal growth factor receptor 2 (proto‐oncogene) (HER2/neu), and thus, IBC is often treated with chemotherapy, radiation, or surgery, due to the lack of targeted therapies.